
Orforglipron Explained: A New Oral GLP-1 for Weight Loss
Episode 13
New oral GLP-1s are changing the weight loss game. Here is what you need to know before recommending or dispensing one. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses how orforglipron, the second oral GLP-1 agonist for weight loss, stacks up against oral semaglutide in terms of dosing, efficacy, safety, and more. This is an excerpt from our May 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription. ****** CE Information: TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses. None of the speakers have anything to disclose. Claim Credit ****** Clinical Resources from Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights: Article: Be Ready for the New Oral GLP-1 Agonist Orforglipron Chart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart Chart: Comparison of Weight Loss Products Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter. 🗪 Send us Fan Mail Email us: ContactUs@trchealthcare.com.
Publisher
Clinical Capsules - Actionable Medication Pearls in Minutes
Published
July 14, 2026
Duration
20 min
Format
Podcast
Category
Lifestyle · Courses
Source
RSS feed
Host
TRC Healthcare | Pharmacist's Letter | Prescriber Insights | Pharmacy Technician's Letter
Clinical Capsules - Actionable Medication Pearls in Minutes
@clinicalcapsulesactionableme
#orforglipronexplained #oralglp #weightloss #medicine #courses
